logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Integrated Biotherapeutics, Inc.

USPTO Granted Patents = 9

% Expired Patents = 11.1


Forward Citations = 17

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Mohammad Javad Aman (9 out of 13 patents)

silverMedal Rajan Prasad Adhikari (6 out of 9 patents)

bronzeMedal Frederick Wayne Holtsberg (4 out of 4 patents)

4.  Hatice Karauzum (4 out of 5 patents)

5.  Katie A Howell (3 out of 3 patents)

6.  Sergey Shulenin (3 out of 3 patents)

7.  Kelly Lyn Warfield (2 out of 13 patents)

8.  Tam Nguyen (2 out of 4 patents)

9.  Xuelian Zhao (1 out of 1 patent)

10.  Yuxing Li (1 out of 7 patents)

11.  Benjamin J Doranz (1 out of 9 patents)

12.  Edgar Davidson (1 out of 1 patent)

13.  Sven G Enterlein (1 out of 1 patent)

14.  Zhen-Yong Keck (1 out of 6 patents)

15.  Steven K H Foung (1 out of 4 patents)


9 patents:

1. 11186626 - Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop (2021-11-30),
2. 11135280 - Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity (2021-10-05),
3. 11028153 - Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins (2021-06-08),
4. 10611827 - Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins (2020-04-07),
5. 10487140 - Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins (2019-11-26),
6. 10174085 - Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof (2019-01-08),
7. 10023848 - Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides (2018-07-17),
8. 9815872 - Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof (2017-11-14),
9. 9109036 - Immunogenic composition comprising alpha-hemolysin oligopeptides (2015-08-18),
Company Overview
Integrated Biotherapeutics, Inc. is a biotechnology company focused on the development of novel vaccines and therapeutic antibodies for emerging infectious diseases. Founded in 2006, the company is dedicated to advancing solutions for global health challenges through innovative research and development. Their team of scientists and researchers work tirelessly to create cutting-edge biologics that address unmet medical needs and improve public health outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Integrated Biotherapeutics, Inc. USPTO Patent Assignee Logo
9 Patents

#75 in Rockville, MD

#449 in Maryland

#32,605 in US

Rockville, MD (US)
Rockville, MD, United States of America

Integrated Biotherapeutics, Inc.

Forward Citations = 17

17 inventors:

goldMedal Mohammad Javad Aman (9 out of 13 patents)

silverMedal Rajan Prasad Adhikari (6 out of 9 patents)

bronzeMedal Frederick Wayne Holtsberg (4 out of 4 patents)

4.  Hatice Karauzum (4 out of 5 patents)

5.  Katie A Howell (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Integrated Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/integrated-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…